SINTX Technologies Hits New 52-Week Low at $1.52 Amid Ongoing Struggles

SINTX Technologies, Inc., a microcap player in the Pharmaceuticals & Biotechnology sector, has reached a new 52-week low of USD 1.52 on July 17, 2026. This significant decline reflects a challenging year for the company, which has seen its stock price plummet by 65.05% over the past year, contrasting sharply with the S&P 500's performance of 18.43% during the same period. The company's financial metrics indicate ongoing difficulties, with a negative return on equity of -349.61% and a debt-to-equity ratio of -1.28. SINTX has reported losses for five consecutive quarters, with net sales for the half-year at USD 0.67 million, down 26.45%. Additionally, the company's return on capital employed (ROCE) stands at a low -311.41%, and its inventory turnover ratio is just 1.12 times. Institutional investor participation has also waned, with a 1.89% decrease in stakes over the previous quarter, leaving them with a collective holding of 11.43%. These factors contribute to a perception of heightened risk surrounding SINTX Technologies, as it continues to struggle with both short-term and long-term performance metrics.